Immunocore Holdings (IMCR) Tax Rate (2021 - 2026)
Immunocore Holdings (IMCR) posted quarterly Tax Rate of 2.27% for Q1 2026, down 1581.0% year-on-year from 0.15% in Q1 2025, and up 102.51% on a QoQ basis from 90.33% in Q4 2025.
Immunocore Holdings (IMCR) Tax Rate (2021 - 2026) Analysis & Trends
Immunocore Holdings (IMCR) has reported Tax Rate for 6 consecutive years, with 2.27% the latest figure, recorded in Q1 2026.
- Quarterly Tax Rate fell 1581.0% year-over-year to 2.27% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 131.57% (down 13637.0% YoY) and the FY2025 annual result came in at 85.94%, down 8943.0% from the prior year.
- Tax Rate climbed to 2.27% in Q1 2026 per IMCR's latest filing, from 90.33% in the prior quarter.
- Over the last five years, Tax Rate for IMCR reached as high as 164.47% in Q3 2025 and fell as low as 90.33% in Q4 2025.
- A 5-year average of 0.44% and a median of 1.61% in 2024 frame the typical range for Tax Rate.
- The largest YoY upside for Tax Rate was 20785 bps in 2025 against a maximum downside of 9456 bps in 2025.
- Year by year, Tax Rate stood at 9.12% in 2022, then surged by 353 bps to 23.05% in 2023, then plunged by 82 bps to 4.23% in 2024, then sank by 2235 bps to 90.33% in 2025, then jumped by 103 bps to 2.27% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 2.27%, 90.33%, and 164.47% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 5.61% |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | 12.29% |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | 33.09% |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 7.07% |
| 10 | Immunocore Holdings | 1.75 Bn | 909.19 Mn | 106.24 Mn | 2.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.27% |
| Mar 31, 2026 | 2.27% |
| Mar 31, 2026 | 2.27% |
| Dec 31, 2025 | -90.33% |
| Dec 31, 2025 | -90.33% |
| Dec 31, 2025 | -90.33% |
| Sep 30, 2025 | 164.47% |
| Sep 30, 2025 | 164.47% |
| Sep 30, 2025 | 164.47% |
| Jun 30, 2025 | -6.25% |
| Jun 30, 2025 | -6.25% |
| Jun 30, 2025 | -6.25% |
| Mar 31, 2025 | 18.08% |
| Mar 31, 2025 | 18.08% |
| Mar 31, 2025 | 18.08% |
| Dec 31, 2024 | 4.23% |
| Dec 31, 2024 | 4.23% |
| Dec 31, 2024 | 4.23% |
| Sep 30, 2024 | -43.38% |
| Sep 30, 2024 | -43.38% |